AACC is pleased to see an additional $2 million for lab test harmonization in the FY 2018 omnibus spending package. The association has worked to advance harmonization – or uniform test results — for more than a decade, most recently leading efforts to raise awareness in Congress of the need for CDC funding for harmonization. AACC is gratified that its multiyear effort has resulted in a positive outcome. The new funding will enable CDC to broaden its harmonization initiative, which is vital to …
.A fingerprint test published today in AACC’s Clinical Chemistry journal can tell whether someone has taken heroin or cocaine, and accurately distinguishes between drug users versus individuals who were exposed to drug residue in the environment. This breakthrough study brings fingerprint drug testing one step closer to clinical adoption, which could revolutionize drug testing by making it both simpler and nearly impossible to cheat.
AACC is pleased to announce that Wall Street Journal investigative reporter John Carreyrou will speak about his investigations into the laboratory medicine industry at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.
WASHINGTON – AACC has issued a new guideline detailing how healthcare providers can use laboratory tests to manage treatment of pain and prevent prescription drug overdoses. Especially relevant in light of the worsening opioid epidemic, the guideline emphasizes increased collaboration between clinicians and laboratory experts as well as the use of more precise drug tests as key to identifying pain patients who are abusing their opioid prescriptions.
As the use of non-invasive prenatal screening (NIPS) grows, there has been concern within the medical community that a poor understanding of this technique among clinicians and patients could negatively impact pregnancies. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives an expert overview of NIPS’s many nuances, to arm healthcare providers with the information they need to ensure patients benefit from this revolutionary but complex technology.
By enabling early disease detection and personalized treatment, laboratory tests can save lives as well as billions in medical costs each year. Join AACC and leading experts in laboratory medicine for a discussion of how clinical tests can be leveraged to achieve these goals, as well as the policies needed to support testing’s vital contribution to healthcare.